Skip to content

Study on the clinical application effect of high pressure treatment combined with pulmonary artery in pregnancy

Study on the clinical application effect of high pressure treatment combined with pulmonary arterial hypertension in pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-14005742
Enrollment
Unknown
Registered
2014-11-23
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary arterial hypertension in pregnancy

Interventions

intervention group: standardized diagnosis and treatment scheme during pregnancy

Sponsors

Beijing An Zhen Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women; 2. According to the diagnostic standard of "2009 European College of Cardiology guidelines for the diagnosis and treatment of pulmonary hypertension in pulmonary arterial hypertension" and the standard of classification, diagnosis of primary pulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease patients; 3. Pregnant women not associated with other serious obstetric complications, such as placenta previa, placental abruption, preeclampsia, eclampsia, etc; 4. Volunteered to participate in this study.

Exclusion criteria

Exclusion criteria: 1. According to the diagnostic standard of "2009 European College of Cardiology guidelines for the diagnosis and treatment of pulmonary hypertension in pulmonary arterial hypertension" and the standard of classification, pregnant women diagnosed as hereditary, thrombosis, portal hypertension, pulmonary disease association and so on, non primary pulmonary hypertension or rheumatic heart disease related pulmonary arterial hypertension; 2. Pregnant women associated with maternal pulmonary hypertension preeclampsia; 3. Pregnant women associated with HELLP syndrome; 4. Pregnant women with pregnancy induced hypertension heart disease pulmonary hypertension; 5. Pregnant women associated with other serious complications; 6. Refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Gestational weeks;Classification of cardiac function;BNP;Arterial Blood Gas;echocardiography;Whole blood cell analysis;Coagulation function;Urine protein;transaminase;CREA;The height of the fundus of uterus;abdominal circumference;BPD;FL;Newborn Apgar score;Newborn weight;FHR;

Countries

China

Contacts

Public ContactJUN ZHANG
drzhangj@outlook.com+86 18910778619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026